Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
Abroad (travel likely)Recruiting
Conditions
Neurofibromatosis 1 · Plexiform Neurofibromas
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's National Medical Center, Washington D.C., District of Columbia, United States
University of Chicago, Chicago, Illinois, United States
Johns Hopkins University, Baltimore, Maryland, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Cincinnati Children's Hospital and Medical Center Institution, Cincinnati, Ohio, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Study leads
Pamela L Wolters, Ph.D.
Principal Investigator
National Cancer Institute (NCI)